Delivery Order SPE2DB20D1004-SPE2DB25FNEWV

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $23,118.45 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,964,631 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This delivery order is part of a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,260.96 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through May 29, 2024. This order was placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $4,114.82 firm fixed price contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, with a performance period ending on May 13, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This is a $13,796.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication, to support military healthcare programs. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
The U.S. Defense Logistics Agency (DLA) awarded a $58,180.33 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565964265 DUPIXENT 300 MG/2 ML PEN 2ML, a prescription pharmaceutical product, with an ultimate completion date of September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that AmerisourceBergen holds with the...
This is a $4,957.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a specialty pharmaceutical product, with a completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,297.66 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of 4560951736 ! DUPIXENT 300 MG/2 ML PEN 2ML medical products, with a period of performance through May 17, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a $23,286.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides 4,566,593,485 units of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication, with a period of performance through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a $35,780.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEWV
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,764.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying essential medical commodities, including specialty medications, generic drugs, and medical devices, to various government agencies and healthcare programs.

Generated 5/14/25, 10:02 AM